The Effects of Low Carbohydrate Diet on Liver Fat Content and Mitochondrial Fluxes
1 other identifier
interventional
10
1 country
1
Brief Summary
The purpose of this study is to examine whether a low carbohydrate diet as compared to simple calorie restriction decreases hepatic lipid content and changes hepatic mitochondrial flux in humans.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Nov 2018
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
November 6, 2018
CompletedFirst Posted
Study publicly available on registry
November 9, 2018
CompletedStudy Start
First participant enrolled
November 15, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 1, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
August 1, 2024
CompletedJuly 24, 2024
July 1, 2024
5.6 years
November 6, 2018
July 23, 2024
Conditions
Outcome Measures
Primary Outcomes (2)
Change in hepatic triglyceride content
Change in hepatic triglyceride content will be measured using 1H magnetic resonance spectroscopy (MRS).
1 week
Change in hepatic mitochondrial flux
Change in the rate of hepatic mitochondrial flux (Vcs) will be assessed using 3-13C-lactate infusion.
1 week
Secondary Outcomes (2)
Change in beta-hydroxybutyrate production rate
1 week
Change in glucose production rate
1 week
Study Arms (2)
Low Carbohydrate Diet
EXPERIMENTALLow Carbohydrate Diet
Simple Calorie Restriction Diet
ACTIVE COMPARATORSimple Calorie Restriction Diet
Interventions
Simple calorie restriction dietary intervention
Eligibility Criteria
You may qualify if:
- Age 18-70
- Subjects must be able to communicate meaningfully with the investigator and must be legally competent to provide written informed consent
You may not qualify if:
- chronic liver disease other than NAFLD
- chronic disease associated with hepatic steatosis such as diabetes mellitus
- use of drugs known to affect hepatic steatosis
- contraindications for MRI
- pregnancy or nursing at the time of the study
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Biomedicum 2U
Helsinki, Uusimaa, 00290, Finland
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Panu Luukkonen
Helsinki University Central Hospital
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- BASIC SCIENCE
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- MD, PhD
Study Record Dates
First Submitted
November 6, 2018
First Posted
November 9, 2018
Study Start
November 15, 2018
Primary Completion
July 1, 2024
Study Completion
August 1, 2024
Last Updated
July 24, 2024
Record last verified: 2024-07
Data Sharing
- IPD Sharing
- Will not share
IPD will be shared as much as our ethics permission and the GDPR regulations of the European Union allow